First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL
R-CHOP联合PDE4抑制剂罗氟司特作为一线治疗方案,用于治疗高危弥漫性大B细胞淋巴瘤。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16223857
Duque, Adolfo E Diaz; Ferrari, Pedro S S M; Ethiraj, Purushoth; Jaafar, Carine; Qiu, Zhijun; Holder, Kenneth; Butler, Mathew J; Huelgas-Morales, Gabriela; Karnad, Anand; Dahia, Patricia L M; Aguiar, Ricardo C T